Literature DB >> 1372476

Substance P: a late-acting B lymphocyte differentiation cofactor.

K L Bost1, D W Pascual.   

Abstract

The peptide substance P has been recognized for years as having dramatic effects on such diverse physiological responses as blood pressure regulation, peristalsis of the gut, and salivation. More recently, demonstration of substance P receptors on leukocytes and modulation of leukocyte functions by this peptide suggested that it might also have a role in immune regulation. This review focuses on the growing body of evidence that demonstrates substance P-induced effects on one population of leukocytes, namely B lymphocytes. Despite the diversity of experimental techniques used, there is surprisingly good agreement as to the role substance P has in modulating B lymphocyte responses. In vivo treatments of rodents, which increase substance P concentrations in the periphery, increase the number of immunoglobulin-secreting cells in these animals. Conversely, infusion of substance P antagonists or depletion of substance P-containing neurons in rodents substantially reduces the animals' ability to synthesize immunoglobulins. With the use of cultures of B lymphocytes it was possible to demonstrate similar results. In the presence of polyclonal B cell activators, substance P augmented immunoglobulin secretion in cultures of purified B lymphocytes or B cell clones. The absence of accessory cells in these cultures suggested that substance P could act directly on activated B lymphocytes, and in fact these B cells were shown to express specific receptors for this peptide. It appears that the substance P receptors expressed by leukocytes are similar or identical to those expressed by neurons as evidenced by radioreceptor binding assays and detection of the gene encoding the substance P receptor.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372476     DOI: 10.1152/ajpcell.1992.262.3.C537

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  The role of magnesium deficiency in cardiovascular and intestinal inflammation.

Authors:  William B Weglicki; Iu Tong Mak; Joanna J Chmielinska; Maria Isabel Tejero-Taldo; Andrei M Komarov; Jay H Kramer
Journal:  Magnes Res       Date:  2010-10-25       Impact factor: 1.115

2.  Bone marrow transplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation.

Authors:  Mara Chavolla-Calderón; Meggan K Bayer; J Julio Pérez Fontán
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.

Authors:  T Goode; J O'Connell; W Z Ho; G C O'Sullivan; J K Collins; S D Douglas; F Shanahan
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Authors:  T Goode; J O'Connell; P Anton; H Wong; J Reeve; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 5.  Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia.

Authors:  Jay H Kramer; Christopher Spurney; Micaela Iantorno; Constantine Tziros; I-Tong Mak; M Isabel Tejero-Taldo; Joanna J Chmielinska; Andrei M Komarov; William B Weglicki
Journal:  Am J Med Sci       Date:  2009-07       Impact factor: 2.378

6.  Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia.

Authors:  William B Weglicki; Joanna J Chmielinska; Isabel Tejero-Taldo; Jay H Kramer; Christopher F Spurney; Kandan Viswalingham; Bao Lu; I Tong Mak
Journal:  Magnes Res       Date:  2009-09       Impact factor: 1.115

7.  A paradoxical protective role for the proinflammatory peptide substance P receptor (NK1R) in acute hyperoxic lung injury.

Authors:  Marwan Dib; Zsuzsanna Zsengeller; Alex Mitsialis; Bao Lu; Stewart Craig; Craig Gerard; Norma P Gerard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-24       Impact factor: 5.464

8.  Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.

Authors:  W B Weglicki; I T Mak; R E Stafford; B F Dickens; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

9.  Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes.

Authors:  Carina Strell; Anne Sievers; Philipp Bastian; Kerstin Lang; Bernd Niggemann; Kurt S Zänker; Frank Entschladen
Journal:  BMC Immunol       Date:  2009-12-08       Impact factor: 3.615

Review 10.  Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.

Authors:  Daria Augustyniak; Judyta Nowak; Fionnuala T Lundy
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.